[1] |
Steponavičienė L, Gudavičienė D, Briedienė R, et al. Diagnosis, treatment, and outcomes of encapsulated papillary carcinoma: A single institution experience[J]. Acta Medica Lituanica, 2018, 25(2): 66-75.
|
[2] |
Amin MB, Edge SB, Green FL, et al. AJCC Cancer Staging Manual. 8th ed[M]. New York: Springer. 2016
|
[3] |
Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Galen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8): 1736-1747.
|
[4] |
Lakhani SR, Ellis IO, Schnitt SJ, et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast[M]. IARC Press: Lyon, France, 2012, 106–107.
|
[5] |
WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th Edition, Volume 2[M]. Lyon, France: IARC; 2019. Introduction in Papillary neoplasms.
|
[6] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
[7] |
Tan H, Tan P, Leong L, et al. Encapsulated papillary carcinoma of the breast: An institutional case series and literature review[J]. Cancer Med, 2023, 12(10): 11408-11416.
|
[8] |
Bonnet SE, Carter GJ, Berg WA. Encapsulated papillary carcinoma of the breast: imaging features with histopathologic correlation[J]. J Breast Imaging, 2020, 2(6): 590-597.
|
[9] |
Athanasiou A, Khomsi F, Joliniere BD, et al. Encapsulated papillary carcinoma: A case report and review of the literature[J]. Front Surg, 2022, 8: 743881.
|
[10] |
Rana MK, Rana APS, Sharma U, et al. Evolution of frozen section in carcinoma breast: systematic review[J]. Int J Breast Cancer, 2022: 4958580.
|
[11] |
Stolnicu S, Rădulescu D, Pleşea IE, et al. The value of intraoperative diagnosis in breast lesions[J]. Rom J Morphol Embryol, 2006, 47(2): 119-123.
|
[12] |
Liu M, Zhao SQ, Yang L, et al. A direct immunohistochemistry (IHC) method improves the intraoperative diagnosis of breast papillary lesions including breast cancer[J]. Discov Med, 2019, 28(151): 29-37.
|
[13] |
Ni Y, Tse GM. Papillary lesions of the breast-review and practical issues[J]. Semin Diagn Pathol, 2022, 39(5): 344-354.
|
[14] |
Liu X, Wu H, Teng L, et al. High-grade encapsulated papillary carcinoma of the breast is clinicopathologically distinct from low/ intermediate - grade neoplasms in Chinese patients[J]. Hislol Histopathol, 2019, 34(2): 137-147.
|
[15] |
Hassan Z, Boulos F, Abbas J, et al. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes[J]. Breast Cancer Res Treat, 2020, 182(2): 317-323.
|
[16] |
Rehman B, Sarfaraz J, Mumtaz A, et al. Papillary carcinoma of breast: clinicopathological characteristics, management, and survival[J]. Int J Breast Cancer, 2022: 5427837.
|
[17] |
Mogal H, Brown D R, Isom S, et al. Intracystic papillary carcinoma of the breast: A SEER database analysis of implications for therapy[J]. Breast, 2016, 27: 87-92.
|
[18] |
Tay TKY, Tan PH. Papillary neoplasms of the breast-reviewing the spectrum[J]. Mod Pathol, 2021, 34(6): 1044–1061.
|
[19] |
Jackson CR, Felty CC, Marotti JD, et al. Encapsulated papillary carcinoma with and without frank invasion: comparison of clinicopathologic features and role of axillary staging[J]. Breast J, 2021, 27(3): 209-215.
|
[20] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021, 31(10): 954-1040.
|